| Identification | Back Directory | [Name]
1,2,5-Oxadiazole-3-carboxamide, N-[(S)-(4,4-difluorocyclohexyl)[7-[(1S)-2-methoxy-1-[(4S)-2-oxo-4-(trifluoromethyl)-1-imidazolidinyl]ethyl]imidazo[1,2-b]pyridazin-2-yl]methyl]-4-(difluoromethyl)- | [CAS]
2452464-77-4 | [Synonyms]
IL-17A inhibitor 2
1,2,5-Oxadiazole-3-carboxamide, N-[(S)-(4,4-difluorocyclohexyl)[7-[(1S)-2-methoxy-1-[(4S)-2-oxo-4-(trifluoromethyl)-1-imidazolidinyl]ethyl]imidazo[1,2-b]pyridazin-2-yl]methyl]-4-(difluoromethyl)- | [Molecular Formula]
C24H25F7N8O4 | [MOL File]
2452464-77-4.mol | [Molecular Weight]
622.5 |
| Hazard Information | Back Directory | [Uses]
IL-17A inhibitor 2 is an IL-17A inhibitor for researching psoriasis, rheumatoid arthritis, and multiple sclerosis. | [IC 50]
IL-17 | [References]
[1] Sabnis RW. Imidazo[1,2-b]pyridazines as IL-17A Inhibitors for Treating Psoriasis, Rheumatoid Arthritis, and Multiple Sclerosis. ACS Med Chem Lett. 2021 Sep 13;12(10):1526-1527. DOI:10.1021/acsmedchemlett.1c00470 |
|
| Company Name: |
BOC Sciences
|
| Tel: |
1-631-485-4226; 16314854226 |
| Website: |
https://www.bocsci.com |
|